Coronavirus: ICMR partners with Bharat Biotech to develop COVID-19 vaccine

Bharat Biotech International Limited (BBIL) has partnered with the Indian Council of Medical Research (ICMR) to develop a fully indigenous vaccine for Coronavirus.

In a statement issued, ICMR said, “The vaccine will be developed by using the virus strain isolated at the ICMR’s National Institute of Virology (NIV) in Pune.”


Adding to the statement, the health research body said, “Work on vaccine development has been initiated between the two partners. The ICMR-NIV will provide continuous support to BBIL for vaccine development.”

“ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies, and clinical evaluation of the candidate vaccine,” it added.

“The strain has been successfully transferred from NIV to BBIL,” the statement further added.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More